Hilary Bok, PhD

Director of Undergraduate Bioethics Program; Associate Professor


3400 North Charles Street
Gilman 278
Baltimore, MD 21218
  • Director of Undergraduate Bioethics Program
    Berman Institute of Bioethics
  • Associate Professor of Philosophy
    Dept. of Philosophy, Johns Hopkins Krieger School of Arts & Sciences

Dr. Bok received a BA in Philosophy from Princeton University in 1981 and her PhD from Harvard University in 1991. She served as Associate Professor of Philosophy at Pomona College from 1997 to 2000. Dr. Bok was also a Laurance S. Rockefeller Visiting Fellow at the Princeton University Center for Human Values from 1994 to 1995. She has authored a book called Freedom and Responsibility. Her areas of specialization are bioethics, moral philosophy, freedom of the will, and the works of Immanuel Kant.

Research Interests

  • Bioethics
  • Moral philosophy
  • Freedom of the will
  • The works of Immanuel Kant


  • PhD, Harvard University
  • BA, Princeton University

Recent Publications

1: Greene M, Schill K, Takahashi S, Bateman-House A, Beauchamp T, Bok H, Cheney
D, Coyle J, Deacon T, Dennett D, Donovan P, Flanagan O, Goldman S, Greely H,
Martin L, Miller E, Mueller D, Siegel A, Solter D, Gearhart J, McKhann G, Faden
R. Ethics: Moral issues of human-non-human primate neural grafting. Science. 2005
Jul 15;309(5733):385-6. PubMed PMID: 16020716.

2: Regenberg A, Mathews DJ, Blass DM, Bok H, Coyle JT, Duggan P, Faden R, Finkel
J, Gearhart JD, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P,
Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Siegel AW, Smith
K, Solter D, Song H, Sugarman J, Vescovi A, Young W, Greely HT, Traystman RJ. The
role of animal models in evaluating reasonable safety and efficacy for human
trials of cell-based interventions for neurologic conditions. J Cereb Blood Flow
Metab. 2009 Jan;29(1):1-9. Epub 2008 Aug 27. Review. PubMed PMID: 18728679;
PubMed Central PMCID: PMC2682696.

3: Bok H, Schill KE, Faden RR. Justice, ethnicity, and stem-cell banks. Lancet.
2004 Jul 10-16;364(9429):118-21. PubMed PMID: 15246711.

4: Faden RR, Dawson L, Bateman-House AS, Agnew DM, Bok H, Brock DW, Chakravarti
A, Gao XJ, Greene M, Hansen JA, King PA, O’Brien SJ, Sachs DH, Schill KE, Siegel
A, Solter D, Suter SM, Verfaillie CM, Walters LB, Gearhart JD. Public stem cell
banks: considerations of justice in stem cell research and therapy. Hastings Cent
Rep. 2003 Nov-Dec;33(6):13-27. Erratum in: Hastings Cent Rep. 2004
Jan-Feb;34(1):4. PubMed PMID: 14983554.

5: Dawson L, Bateman-House AS, Mueller Agnew D, Bok H, Brock DW, Chakravarti A,
Greene M, King PA, O’Brien SJ, Sachs DH, Schill KE, Siegel A, Solter D, Suter SM,
Verfaillie CM, Walters LB, Gearhart JD, Faden RR. Safety issues in cell-based
intervention trials. Fertil Steril. 2003 Nov;80(5):1077-85. Review. Erratum in:
Fertil Steril. 2004 Jan;81(1):226. PubMed PMID: 14607552. http://www.ncbi.nlm.nih.gov/pubmed/14607552

6: Bok H. What’s wrong with confusion? Am J Bioeth. 2003 Summer;3(3):25-6. PubMed
PMID: 14594478. http://www.ncbi.nlm.nih.gov/pubmed/14594478